Target intelligence / Profile preview

Apolipoprotein E Receptor (ApoE Receptor)

Target
ApoE Receptor
Molecular classification
Receptor, Low-Density Lipoprotein Receptor Family, Cell Surface Receptor, Heparan Sulfate Proteoglycan
01

Overview

The term "Apolipoprotein E receptor" refers to a group of cell-surface receptors that bind apolipoprotein E (apoE), a key protein involved in lipid metabolism, neuronal maintenance, and neurodegenerative disease processes. These receptors are primarily members of the low-density lipoprotein receptor (LDLR) family and play essential roles in mediating the uptake and cellular effects of apoE-containing lipoproteins. Major receptor types include LDLR, LRP1, VLDLR, ApoER2/LRP8, and Heparan Sulfate Proteoglycans. They are involved in various biological functions such as mediating endocytosis/clearance of triglyceride-rich lipoproteins, regulating cholesterol transport, facilitating cholesterol delivery in the CNS, modulating cellular processes, and influencing susceptibility to neurodegenerative diseases. Dysfunction or altered expression contribute to hyperlipidemias, atherosclerosis, and neurodegenerative disorders including Alzheimer's disease. Recent research highlights potential therapeutic targeting opportunities.

Other names
LDLR family receptors for ApoEApoE receptorsLDL ReceptorLRP1VLDLRApoER2LRP8Heparan Sulfate Proteoglycans
02

Mechanism of action

Enhancing protective signaling via APOER2; modulating amyloid beta deposition/toxicity

03

Biological functions

Lipid uptakeCholesterol transportEndocytosisSignal transductionSynaptic plasticityNeuronal survivalLipoprotein clearance
04

Disease associations

HyperlipidemiaAtherosclerosisAlzheimer's diseaseNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Potential for off-target effects due to broad expression of receptor family membersComplex interplay of ApoE isoforms and receptor subtypes requires careful consideration in therapeutic design

Beyond the preview

Go deeper on Apolipoprotein E Receptor (ApoE Receptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apolipoprotein E Receptor (ApoE Receptor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call